AGEZI IGBOKO: Open Payments
NPI 1790350882 · ELMIRA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,561 in 99 payments from 19 companies in 2025. Trend: 2023 $906 · 2024 $2,662 · 2025 $1,561
Food & beverage: $1,506Education: $55
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $241 |
| Novartis Pharmaceuticals Corporation | 10 | $213 |
| Janssen Biotech, Inc. | 11 | $208 |
| E.R. Squibb & Sons, L.L.C. | 25 | $163 |
| Arcutis Biotherapeutics, Inc. | 9 | $138 |
| Lilly USA, LLC | 3 | $89 |
| ABBVIE INC. | 3 | $80 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $64 |
| PFIZER INC. | 3 | $60 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $53 |
Products named: Bimzelx, TREMFYA, Sotyktu, COSENTYX, Zoryve, TALTZ, ILUMYA, SKYRIZI.
Industry payments across NY — which companies pay providers there.
